Rob Jepras

Dr Rob Jepras has worked in and led several research teams in both industry and public health. He spent 30 years at GSK working in both Drug Development and Drug Discovery supporting both product development and drug research. More recent work has focused on using high content multi parametric microscopic technologies for phenotyic screening using human disease relevant systems, and the develpoment of microscale technologies (microfluidics/nanowells) to enhance drug discovery efforts. Rob is currently a Vice President at Curve Theraputics, working on novel drug modalities agaist cancer targets.

Rob is also an Honorary Fellow at the University of Liverpool and is an ELRIG conference Director.